Nalaganje...
Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?
Transcatheter aortic valve replacement (TAVR) has become an established therapeutic option for patients with symptomatic, severe aortic valve stenosis at increased surgical risk. Antithrombotic therapy after TAVR aims to prevent transcatheter heart valve (THV) thrombosis, in which two different enti...
Shranjeno v:
| izdano v: | Front Cardiovasc Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6482296/ https://ncbi.nlm.nih.gov/pubmed/31058168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00044 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|